DocGo Inc. Faces Investigation Over Alleged Securities Violations

The Schall Law Firm, a prominent national shareholder rights litigation firm, has announced that it is conducting an investigation into DocGo Inc. (NASDAQ: DCGO) on behalf of investors. The investigation is centered around potential violations of securities laws, with a focus on whether the company issued false or misleading statements and failed to disclose pertinent information to investors.

DocGo, a leading healthcare provider, came under scrutiny following the publication of a report by Fuzzy Panda Research on January 10, 2024. The report alleged that the company engaged in “systematic billing fraud” by forging signatures on documents, fraudulently altering patient records, and billing for tests that were not performed. As a result, shares of DocGo plummeted by over 37% on the same day.

The Schall Law Firm is inviting shareholders who suffered losses to participate in the investigation. The firm encourages affected individuals to contact Brian Schall, an experienced attorney specializing in securities class action lawsuits and shareholder rights litigation. Mr. Schall can be reached at the firm’s office in Los Angeles, California, or through their website or email address provided.

DocGo Inc. is a healthcare company committed to providing quality services to its patients. While the investigation is ongoing, it is important to note that these allegations have not been proven. The company has not yet issued a public response to the report or the investigation. It is crucial to allow the legal process to unfold and reach a fair conclusion.

Investor confidence is a vital aspect of any company’s success, and maintaining transparency and integrity is crucial. DocGo Inc. has an opportunity to address these allegations and provide clarity to its shareholders. As the investigation progresses, it is hoped that the company will cooperate fully and take appropriate measures to ensure the trust and confidence of its investors.

Please note that this press release may be considered Attorney Advertising in some jurisdictions under applicable law and rules of ethics.

Contact:
The Schall Law Firm
Brian Schall, Esq.
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com

Comments (0)
Add Comment